Good that MSB still has Fast Track Designation and BLA Priority Review. By March 23' we will have confirmation one way or other, and given there is still no cure for children under 12 years old and that MSB have now shown how potency assays predict survival outcomes and better controls, you would hope it's a compelling case.
Ann: Submits New Information to FDA IND File for SR-aGVHD, page-8
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.045(3.83%) |
Mkt cap ! $1.295B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.19 | $1.12 | $7.830M | 6.859M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1241 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.14 | 79717 | 23 |
View Market Depth
| Last trade - 13.11pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.13 |
Change
-0.045 ( 4.33 %) |
||||
| Open | High | Low | Volume | ||
| $1.17 | $1.17 | $1.12 | 840408 | ||
| Last updated 13.30pm 08/05/2024 ? | |||||
| MSB (ASX) Chart |